Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Operating Income (2019 - 2025)

Historic Operating Income for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$17.6 million.

  • Outset Medical's Operating Income rose 1935.5% to -$17.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$66.7 million, marking a year-over-year increase of 4116.34%. This contributed to the annual value of -$66.7 million for FY2025, which is 4116.34% up from last year.
  • Outset Medical's Operating Income amounted to -$17.6 million in Q4 2025, which was up 1935.5% from -$15.8 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Operating Income registered a high of -$15.8 million during Q3 2025, and its lowest value of -$45.5 million during Q3 2023.
  • Over the past 5 years, Outset Medical's median Operating Income value was -$33.6 million (recorded in 2022), while the average stood at -$32.1 million.
  • Its Operating Income has fluctuated over the past 5 years, first tumbled by 4683.82% in 2021, then surged by 5557.27% in 2025.
  • Over the past 5 years, Outset Medical's Operating Income (Quarter) stood at -$40.8 million in 2021, then increased by 2.39% to -$39.8 million in 2022, then increased by 6.2% to -$37.4 million in 2023, then soared by 41.48% to -$21.9 million in 2024, then rose by 19.35% to -$17.6 million in 2025.
  • Its Operating Income was -$17.6 million in Q4 2025, compared to -$15.8 million in Q3 2025 and -$16.9 million in Q2 2025.